Melphalan Market by Dosage (Product (Kit, Tablet, Film Coated and Injection Powder, lyophilized for Solution) Route (Oral (2 mg/1, 2MG, 5MG) and Intra-arterial, Intravenous 50 mg/10 ml), by Indication (Multiple Myeloma, Ovarian Cancer, Neuroblastoma, Rhabdomyosarcoma, Breast Cancer, Used in some Conditioning Regimens Prior to Bone Marrow Transplant, Non-resectable Epithelial Carcinoma of the Ovary, Recurrent or Unresectable in-transit Metastatic Melanoma, Treatment of Amyloidosis with Prednisone, Adjunct to Surgery in the Treatment of Breast Cancer and Others (Severe Hodgkin Lymphoma, etc.)) By Region (Northeast, Midwest, Wets and South) – United States Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028
Report ID :AMI-721 | Category : Healthcare & IT | Published Date : November, 2020 | Pages : 420 | Format :PDF